Selank

Research Use Only Disclaimer

Selank is sold strictly for laboratory, academic and institutional research. It is not for human or animal consumption, injection, or any therapeutic, diagnostic or veterinary use.

PCH Peptides does not provide dosage, administration or usage guidance. The product is supplied exclusively for qualified researchers working in controlled laboratory environments.

What Is Selank?

Selank is a synthetic heptapeptide composed of seven amino acid residues arranged in the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

The peptide was developed through research at the Institute of Molecular Genetics in Moscow, Russia, using the naturally occurring tetrapeptide tuftsin as its structural foundation.

Tuftsin consists of the sequence Thr-Lys-Pro-Arg and is investigated for its involvement in immune-related cellular signalling.

Selank extends this sequence by adding Pro-Gly-Pro, a three-amino-acid fragment associated with modifications to peptide stability and susceptibility to enzymatic degradation.

This structural modification distinguishes Selank from its parent peptide and makes it relevant to laboratory investigations involving peptide stability and regulatory signalling mechanisms.

Researchers investigate Selank in neuropeptide research, including experimental models involving GABAergic signalling, neurotrophic factor expression and cellular molecular interactions.

Its structure is also compared with Semax, another synthetic research peptide containing a Pro-Gly-Pro sequence.

Although these compounds share a structural fragment, they originate from different parent peptide sequences and are investigated in different experimental research models.

For additional background on peptide structure and laboratory research applications, explore the What Are Peptides? Research Guide.

Selank 10mg Specifications

Selank in Laboratory Research

Selank is investigated in biochemical and cellular models involving neuropeptide chemistry, molecular signalling, peptide stability and regulatory peptide interactions.

Neuropeptide Signalling Research

Selank is studied in experimental models involving neuropeptide-associated cellular signalling.

Researchers investigate its molecular characteristics and potential interactions with signalling systems involved in neuronal communication.

Some preclinical investigations have examined Selank in models associated with GABAergic signalling.

GABAergic signalling involves gamma-aminobutyric acid (GABA), an important inhibitory neurotransmitter in the central nervous system.

Laboratory research may examine changes in signalling markers, receptor-related responses and molecular interactions under controlled experimental conditions.

However, the precise molecular mechanisms underlying Selank’s reported experimental effects remain incompletely established.

GABAergic System Research

The GABAergic system is investigated in neuroscience research because of its role in inhibitory neuronal signalling.

Selank has been examined in preclinical studies involving molecular systems associated with GABA-related signalling.

Researchers may investigate gene expression, receptor-associated molecular changes and cellular responses in suitable experimental models.

Selank should not be assumed to act as a direct GABA receptor agonist solely because of its association with GABAergic research.

Its specific molecular targets and interactions require further scientific investigation.

Neuropeptide and Neurotrophic Factor Studies

Selank has also been investigated in laboratory research involving neurotrophic factor expression and neuronal cellular responses.

Neurotrophic factors are proteins involved in neuronal development, cellular maintenance and signalling.

Researchers may examine how experimental peptide exposure relates to changes in gene expression or molecular markers associated with neuronal cell models.

These investigations contribute to understanding the characteristics of synthetic regulatory peptides.

Findings from preclinical research should not be interpreted as evidence of established therapeutic effectiveness in humans.

Tuftsin-Derived Peptide Research

Tuftsin is a naturally occurring tetrapeptide with the sequence Thr-Lys-Pro-Arg.

Selank contains this four-amino-acid sequence followed by Pro-Gly-Pro.

Researchers compare Selank with tuftsin and other related peptide fragments to examine how structural modifications influence molecular stability and experimental biological interactions.

These comparative studies may involve peptide characterization, analytical chemistry and cellular signalling models.

The addition of Pro-Gly-Pro is an important structural distinction between Selank and its parent tetrapeptide.

Peptide Stability and Molecular Characterization

Selank is also relevant to laboratory studies involving synthetic peptide stability, structural characterization and analytical method development.

Its defined seven-amino-acid sequence allows researchers to investigate chemical properties and peptide degradation under controlled conditions.

Studies may examine how the peptide’s structure influences its stability and interactions with experimental environments.

These investigations are non-clinical and do not establish the safety or effectiveness of research-grade Selank for human use.

Certificate of Analysis

PCH Peptides provides batch-specific analytical documentation for its Selank research material.

The PCH Peptides COA Library currently lists one Certificate of Analysis and one endotoxin report for Selank.

Researchers should review the applicable batch Certificate of Analysis to confirm compound identity, HPLC purity percentage and other available analytical findings.

The exact purity percentage should be taken directly from the current batch documentation rather than assumed from general product specifications.

The endotoxin report should be reviewed separately because endotoxin testing and HPLC purity testing measure different aspects of material quality.

Batch-specific documentation helps laboratories evaluate material identity, analytical consistency and traceability.

For additional background on research material classifications and testing documentation, review the Research Use Only Peptides Guide.

Storage and Handling

Keep the Selank vial sealed until required for an authorized laboratory workflow.

Store the lyophilized material in a cold, dry environment protected from moisture, excessive heat and direct light.

Follow the storage temperature and handling recommendations printed on the product label and applicable batch-specific documentation.

Appropriate storage conditions help maintain the integrity of synthetic peptides during laboratory handling and molecular analysis.

Avoid using material from containers with damaged packaging, broken seals or uncertain identification.

Reconstitution Solution is available separately for appropriate laboratory applications, subject to compatibility with the intended research workflow.

Researchers seeking general information about lyophilized peptide handling can review the educational guide on how peptide reconstitution works.

Related Research Materials

Laboratories investigating neuropeptide chemistry, regulatory signalling and short-peptide molecular interactions may also examine other research compounds.

• Semax – A synthetic peptide based on an ACTH fragment analogue, containing a Pro-Gly-Pro sequence. It is investigated in neuropeptide chemistry, molecular signalling and peptide stability research.
• DSIP – Delta Sleep-Inducing Peptide, a synthetic nonapeptide studied in neuropeptide chemistry, receptor-ligand screening and molecular characterization.
• Pinealon – A synthetic tripeptide with the sequence Glu-Asp-Arg (EDR), investigated in short regulatory peptide research, neuronal cell models and molecular stability studies.
• Epithalon – A synthetic tetrapeptide containing Ala-Glu-Asp-Gly, studied in laboratory models involving cellular regulation, gene expression and short-peptide characterization.

These compounds differ in amino acid sequence, molecular structure and experimental research applications.

Selank and Semax share the Pro-Gly-Pro fragment but are derived from different parent peptide sequences.

DSIP, Pinealon and Epithalon are investigated in other areas of neuropeptide chemistry and regulatory peptide research.

Researchers can explore additional compounds through the PCH Peptides research peptide catalog.

Frequently Asked Questions

What is Selank peptide?

Selank is a synthetic seven-amino-acid peptide derived from the naturally occurring tetrapeptide tuftsin.

Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Researchers investigate Selank in controlled laboratory studies involving neuropeptide chemistry, molecular signalling and peptide stability.

What is the Selank amino acid sequence?

Selank contains seven amino acid residues arranged in the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Its single-letter sequence is TKPRPGP.

The peptide has a molecular formula of C33H57N11O9 and an approximate molecular weight of 751.9 g/mol.

What is Selank derived from?

Selank is derived from tuftsin, a naturally occurring tetrapeptide with the amino acid sequence Thr-Lys-Pro-Arg.

Selank contains this sequence with an additional Pro-Gly-Pro fragment at its C-terminus.

The structural modification distinguishes it from tuftsin and is relevant to laboratory investigations of peptide stability and molecular interactions.

What is Selank used for in research?

Selank is investigated in laboratory studies involving neuropeptide chemistry, GABAergic-associated signalling, regulatory peptide interactions and molecular characterization.

Researchers also examine its structure, stability and potential interactions with neuronal signalling systems.

These applications remain experimental and do not establish therapeutic effectiveness or safety for human use.

What is the difference between Selank and Semax?

Both Selank and Semax are synthetic research peptides that contain a Pro-Gly-Pro sequence.

Selank is derived from the naturally occurring tetrapeptide tuftsin and has the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Semax is based on an adrenocorticotropic hormone (ACTH) fragment analogue and has a different amino acid sequence.

Researchers investigate the two compounds in overlapping areas of neuropeptide chemistry, although their molecular structures and experimental profiles differ.

Does Selank act on GABA receptors?

Selank has been investigated in preclinical models involving GABAergic signalling.

However, its precise molecular targets remain incompletely characterized, and it should not be described as an established direct GABA receptor agonist.

Researchers continue to examine its potential signalling interactions through controlled laboratory experiments.

What is the molecular weight of Selank?

Selank has an approximate molecular weight of 751.9 g/mol and a molecular formula of C33H57N11O9.

These values describe the reference peptide structure. Any salt-form or formulation-specific differences should be verified against the applicable batch documentation.

What size does Selank come in?

PCH Peptides supplies Selank as a 10mg lyophilized research material in a single vial.

The product is intended exclusively for qualified laboratory, academic and institutional research applications.

Is Selank batch tested?

The PCH Peptides COA Library lists one Certificate of Analysis and one endotoxin report for Selank.

Researchers should review the applicable batch documentation to verify compound identity, purity and available analytical testing results.

Available certificates can be accessed through the COA Library.

How should Selank be stored?

Selank should remain sealed and protected from moisture, excessive heat and direct light.

Follow the storage temperature and handling recommendations printed on the product label and any applicable batch-specific documentation.

Appropriate storage conditions help maintain the integrity of lyophilized peptide research materials.

Is Selank intended for human or animal use?

No. Selank is supplied strictly for laboratory, academic and institutional research.

It is not intended for human or animal consumption, injection, therapeutic applications, diagnosis or veterinary use.

For additional information about research-use classifications, review the Research Use Only Peptides Guide.

Do you provide dosage instructions for Selank?

No. PCH Peptides does not provide dosage, administration or usage protocols. Selank is supplied exclusively for qualified research use only.